Aptivus
Product Images NDC 0597-0003

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Aptivus (NDC 0597-0003). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Boehringer Ingelheim Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula (Aptivus 01)

A data table displaying a mathematical expression involving height in centimeters, weight in kilograms, and the constant 3600. It appears to show a formula related to the square root of the ratio of height and weight multiplied by 3600.*

FDA Label Image

Chemical Structure (Aptivus 02)

Chemical structure of the active ingredient in Aptivus, showing a complex molecule with multiple rings including a benzene, pyridine, and sulfonamide group, along with hydroxyl and trifluoromethyl substituents.*

FDA Label Image

Figure 1 (Aptivus 03)

The chart displays mean plasma concentrations over time of Tipranavir and Ritonavir, including a 95% confidence interval for Tipranavir. The x-axis represents time in hours, and the y-axis shows concentration levels in µM for Tipranavir and µg/mL for Ritonavir.*

FDA Label Image

Image (Aptivus 04)

FDA Label Image

Principal Display Panel (250 mg Capsule Bottle Label)

Label for Aptivus capsules 250 mg by Boehringer Ingelheim Pharmaceuticals, Inc. The label states the product contains 120 capsules of tipranavir, with 7% dehydrated alcohol per capsule. It includes storage instructions to refrigerate prior to opening and keep at specified temperatures after opening. The label features a red alert box advising to find out about medicines that should not be taken with Aptivus and notes for pharmacists not to cover the alert box. A barcode and distributor information are also present.*

FDA Label Image

Principal Display Panel (95 mL Bottle Label)

Aptivus (tipranavir) Oral Solution 100 mg/mL 95 mL unit of use container label. Includes an alert about medicines that should not be taken with Aptivus. Provides storage instructions (15-25°C, do not refrigerate or freeze), usage timeline (within 60 days after opening), and dosing reference to accompanying prescribing information. Distributed by Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT. Contains barcodes and lot/expiration placeholders.*

FDA Label Image

Principal Display Panel (95 mL Bottle Carton)

Carton packaging label for Aptivus oral solution, 100 mg/mL, manufactured by Boehringer Ingelheim Pharmaceuticals, Inc. The label includes dosage form, concentration, volume of 95 mL, and NDC 0597-0002. It features warnings, storage instructions, lot number, barcodes, and company logos, with a design of dark blue and orange side panels on a white background.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.